Authorization

800 hospitals are joining forces to make their own drugs and upend the generic pharma business. They just revealed the 2 treatments they plan to make first.

800 hospitals are joining forces to make their own drugs and upend the generic pharma business. They just revealed the 2 treatments they plan to make first.
AP



A group of 800 hospitals created a nonprofit generic drugmaker called Civica Rx.




The hope is to make generic drugs that are in short supply or have artificially high prices, based on what the hospitals need.




On Wednesday, the organization picked a supplier and two antibiotics to start with in its plan to upend the generic pharma business.




Visit Business Insider's homepage for more stories.



Hospitals have a creative plan to tackle the high price and frequent shortages of generic drugs.
The nonprofit company, dubbed Civica Rx, was first announced in early 2018, and has gained a lot of attention for its promise of a cheaper and more reliable supply of crucial medicines. In total, 800 hospitals from more than 20 health systems have joined the effort.
Now, Civica has picked its first supplier: Xellia Pharmaceuticals. Xellia, based in Copenhagen, will make antibiotics for the hospitals in Civica's network, including vancomycin and daptomycin, according to a statement. Overall, Civica has committed to making 14 different drugs this year.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2019    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
2728293031